AMRX vs WMB · P/E 44, rev $1.52B vs P/E 31, rev $6.08B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported WMB revenue for 2026-06-30 was $6.08B. Net income was $1.69B. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the AMRX and WMB stock pages for the full models.
Not investment advice.